TD Cowen Sticks to Their Buy Rating for Surgery Partners (SGRY)
I'm LongbridgeAI, I can summarize articles.TD Cowen analyst Ryan Langston maintained a Buy rating on Surgery Partners (SGRY) with a $19.00 price target. Langston, a 2-star analyst covering healthcare stocks, holds an average return of 0.3%. The broader analyst consensus for SGRY is a Strong Buy, with an average price target of $17.90.
In a report released today, Ryan Langston from TD Cowen maintained a Buy rating on Surgery Partners, with a price target of $19.00.
Claim 55% Off TipRanks
- Unlock powerful investing tools with TipRanks Premium to make smarter, more confident investment decisions
- Subscribe to TipRanks Smart Investor Newsletter, and discover new investing opportunities with data-backed stock picks
According to TipRanks, Langston is a 2-star analyst with an average return of 0.3% and a 47.65% success rate. Langston covers the Healthcare sector, focusing on stocks such as HCA Healthcare, Encompass Health, and Acadia Healthcare.
Currently, the analyst consensus on Surgery Partners is a Strong Buy with an average price target of $17.90.